LY CONFIDENTIAL 21 EFTA00586877 sensitive mutation detection to enable accurate tumor profiling and real-time monitoring of tumor evolution. The OnTarget assay reveals tumor mutations that are undetectable with other methods to help guide selection of therapy, improve clinical trial efficiency, and ac